New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 1, 2014
06:18 EDTPACBPacific Biosciences upgraded to Neutral from Underweight at JPMorgan
JPMorgan upgraded Pacific Biosciences to Neutral citing valuation and stronger system placements following the company's Q1 results. The firm has a $7 price target for shares.
News For PACB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 27, 2014
17:05 EDTPACBPacific Biosciences announces SLPC established new genomics facility
Subscribe for More Information
October 23, 2014
16:04 EDTPACBPacific Biosciences reports Q3 EPS (13c), consensus (16c)
Subscribe for More Information
October 22, 2014
11:34 EDTPACBLeerink's life science tools analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use